Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Lidco Group Plc LSE:LID London Ordinary Share GB0030546849 ORD 0.5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 6.75 186,270 08:00:00
Bid Price Offer Price High Price Low Price Open Price
6.50 7.00 6.75 6.75 6.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 7.55 -1.21 -0.42 16
Last Trade Time Trade Type Trade Size Trade Price Currency
14:02:50 O 2,122 6.975 GBX

Lidco (LID) Latest News

More Lidco News
Lidco Takeover Rumours

Lidco (LID) Discussions and Chat

Lidco (LID) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
13:02:516.982,122148.01O
13:00:096.98503.49O
08:57:486.6220,2441,340.15O
08:46:467.004,000280.00O
08:39:376.9010,000690.00O
View all Lidco trades in real-time

Lidco (LID) Top Chat Posts

DateSubject
04/6/2020
09:20
Lidco Daily Update: Lidco Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker LID. The last closing price for Lidco was 6.75p.
Lidco Group Plc has a 4 week average price of 6.75p and a 12 week average price of 3.75p.
The 1 year high share price is 10.75p while the 1 year low share price is currently 3.40p.
There are currently 244,174,908 shares in issue and the average daily traded volume is 553,948 shares. The market capitalisation of Lidco Group Plc is £16,481,806.29.
13/4/2020
14:12
trentendboy: Very funny Nobby - to spin a pro DoomedTex story out of recent share price moves is remarkable.
13/4/2020
11:33
nobbygnome: So LID valued at £18.3 million and the share price going down......and DEMG £8.1 million with better more flexible technology and the share price going up. Which do we think is better value? Answers on a post card please....
06/4/2020
22:16
nobbygnome: Because of the ramping of the LID price by the usual suspects, it is clear the value can be obtained by buying DEMG. Clearly LID which has the inferior technology in this regard now is overvalued. I am beginning to doubt buywell understands how the market works....
03/4/2020
11:04
gbenson1: Share price seems to be jumping around to the downside without any trades! Is there an RNS about to drop or is there a late reported large sell trade to come?
12/3/2020
00:30
buywell3: The scale of the Covid-19 problem has just risen: Coronavirus: Up to 70% of Germany could get infected with COVID-19, Merkel says hTtps://www.pix11.com/news/coronavirus/coronavirus-up-to-70-of-germany-could-get-infected-with-covid-19-merkel-says ------------ RNS and a new NOMAD , N+1 Singer --------------- It is to be hoped that the new NOMAD , N+1 Singer will produce some decent new research notes to promote LiDCO and to show how their HUP initiatives are bearing fruit. A new forward looking LiDCO share price prediction will IMO follow to reflect recent acquisitions of smaller companies involved in the manufacture of Hemodynamic Monitors. Companies it should be noted that did not currently supply the NHS with 60% of its Hemodynamic Monitors as LiDCO does, plus recent increased HUP sales and sales into China. Companies that did not have a China based Hemodynamic Monitor manufacturing facility , as LiDCO has. htTps://www.investegate.co.uk/lidco-group-plc--lid-/rns/latest-monitor-launched-in-china/201911050700052267S/ Covid -19 developments that buywell has eluded to in recent posts will one would think factor quite highly in such. ----------- The WHO has just declared Covid -19 a pandemic ----------- The new chancellor of the exchequer in the budget announcement, regarding the coming fight against Covid-19 has just announced : The NHS will get 1) Whatever it needs 2) Whatever it costs buywell recent posts has stated where this fight to save lives will take place , the battlefield will be in Hospital Intensive Care Units ( ICU's). This is where around 15% of patients that develop viral pneumonia , then circa 5% that develop septic shock and sepsis following on from viral pneumonia , will have to be treated. buywell believes the monies to buy Hmodynamic Monitoring equipment , which LiDCO has clinically showed to save lives in such circumstances , has been paid for by anaesthetists. Stats improvements in lives saved, reduction in length of stay (LOS) , and reduced complications stats , have to the best of my knowledge NOT been shown against the anaesthetists who bought and paid for the Hemodynamic Monitors but have shown improved stats for other parts of the Hospital. The NHS as we all know is now very stats driven In Italy ICU's are struggling to cope with the Covid-19 burden being placed upon them Germany has just announced it expects circa 60% of its population to acquire Covid-19 The junior minister for health Narine Dorries has just acquired it herself htTps://www.smh.com.au/world/europe/uk-health-minister-nadine-dorries-diagnosed-with-coronavirus-20200311-p548wl.html buywell expects many other members of the government will also acquire it, some of the elder ones will get treated in ICU's. The time is therefore ripe for the NHS to purchase Hemodynamic Monitoring equipment in those Hospitals and Trusts where monies have been too tight to allow its purchase, the chancellor has just stated '' whatever the cost '' LiDCO buywell thinks , will be revisiting ALL Hospitals and Trusts to explain once more the merits of using their equipment via their HUP deal ( costs spread over 3 to 5 years) , with a list showing all those 25% of NHS Hospitals that have to date now switched to such a deal (HUP) with an NHS contact name , so that they can be referenced to gain relevant data regarding the NHS benefits to patients from the NHS horses mouth. Important: The use of Hemodynamic Monitoring in sepsis and septic shock has very clearly been clinically demonstrated hTtp://www.lidco.com/case-study/sepsis/ hTtp://www.lidco.com/education/how-to-save-lives-in-sepsis/ Covid-19 will at some point have a vaccine made to fight against it, maybe 12 to 18 months away. Other Coronaviruses are on the way however which will have similar symptoms , viral pneumonia , septic shock and sepsis. buywell's point being : The purchase of Hemodynamic Monitoring units now to fight Covid-19 will NOT be wasted once it goes away. IMO LiDCO could receive many orders from around the world as death rates look set to rise due to a lack of ICU hospital beds and a lack of Hemodynamic Monitors. dyor
12/3/2020
00:11
buywell3: ------------ RNS and a new NOMAD , N+1 Singer --------------- It is to be hoped that the new NOMAD , N+1 Singer will produce some decent new research notes to promote LiDCO and to show how their HUP initiatives are bearing fruit. A new forward looking LiDCO share price prediction will IMO follow to reflect recent acquisitions of smaller companies involved in the manufacture of Hemodynamic Monitors. Companies it should be noted that did not currently supply the NHS with 60% of its Hemodynamic Monitors as LiDCO does, plus recent increased HUP sales and sales into China. Companies that did not have a China based Hemodynamic Monitor manufacturing facility , as LiDCO has. htTps://www.investegate.co.uk/lidco-group-plc--lid-/rns/latest-monitor-launched-in-china/201911050700052267S/ Covid -19 developments that buywell has eluded to in recent posts will one would think factor quite highly in such. ----------- The WHO has just declared Covid -19 a pandemic ----------- The new chancellor of the exchequer in the budget announcement, regarding the coming fight against Covid-19 has just announced : The NHS will get 1) Whatever it needs 2) Whatever it costs buywell recent posts has stated where this fight to save lives will take place , the battlefield will be in Hospital Intensive Care Units ( ICU's). This is where around 15% of patients that develop viral pneumonia , then circa 5% that develop septic shock and sepsis following on from viral pneumonia , will have to be treated. buywell believes the monies to buy Hmodynamic Monitoring equipment , which LiDCO has clinically showed to save lives in such circumstances , has been paid for by anaesthetists. Stats improvements in lives saved, reduction in length of stay (LOS) , and reduced complications stats , have to the best of my knowledge NOT been shown against the anaesthetists who bought and paid for the Hemodynamic Monitors but have shown improved stats for other parts of the Hospital. The NHS as we all know is now very stats driven In Italy ICU's are struggling to cope with the Covid-19 burden being placed upon them Germany has just announced it expects circa 60% of its population to acquire Covid-19 The junior minister for health Narine Dorries has just acquired it herself htTps://www.smh.com.au/world/europe/uk-health-minister-nadine-dorries-diagnosed-with-coronavirus-20200311-p548wl.html buywell expects many other members of the government will also acquire it, some of the elder ones will get treated in ICU's. The time is therefore ripe for the NHS to purchase Hemodynamic Monitoring equipment in those Hospitals and Trusts where monies have been too tight to allow its purchase, the chancellor has just stated '' whatever the cost '' LiDCO buywell thinks , will be revisiting ALL Hospitals and Trusts to explain once more the merits of using their equipment via their HUP deal ( costs spread over 3 to 5 years) , with a list showing all those 25% of NHS Hospitals that have to date now switched to such a deal (HUP) with an NHS contact name , so that they can be referenced to gain relevant data regarding the NHS benefits to patients from the NHS horses mouth. Important: The use of Hemodynamic Monitoring in sepsis and septic shock has very clearly been clinically demonstrated hTtp://www.lidco.com/case-study/sepsis/ hTtp://www.lidco.com/education/how-to-save-lives-in-sepsis/ Covid-19 will at some point have a vaccine made to fight against it, maybe 12 to 18 months away. Other Coronaviruses are on the way however which will have similar symptoms , viral pneumonia , septic shock and sepsis. buywell's point being : The purchase of Hemodynamic Monitoring units now to fight Covid-19 will NOT be wasted once it goes away. IMO LiDCO could receive many orders from around the world as death rates look set to rise due to a lack of ICU hospital beds and a lack of Hemodynamic Monitors. dyor
16/4/2019
11:48
multibagger: 10p in 2021 from a share price point of view would be an excellent return for someone who has recently invested (like me this time around). However, this does not change my view on the laissez faire approach to performance related options in LID. Options cause dilution of equity and to the detriment of shareholders if share price performance does not justify them. Matt has been given a lot of options over the years, but this has not translated into share price performance - what we have seen is a steady decline in share price and good or bad, the buck stops with him. I am already a share holder / fractional owner of the LID business (knowing fully well that I can easily take a RNS notifiable stake at short notice), however, I will not do so, as RNS today does not reflect good corporate culture or governance in my view. I am going to see how this pans out, but at this time I am not impressed in the slightest and intuitively a red flag. It feels wrong to me and I heed my intuition. We may have to agree to disagree on this one buywell2 !
16/4/2019
07:25
pugugly: The Company is currently in the process of finalising share option grants to key employees over a further 1,025,000 Ordinary shares. Following these grants, the total number of shares under option will be 20,478,376 representing 8.4% of the issued share capital. https://www.investegate.co.uk/lidco-group-plc--lid-/rns/award-of-share-options-director-dealing/201904160700142619W/ A proportion of the Options may vest and be exercised at 0.5 pence per Ordinary Share anytime between 9 April 2022 and 9 April 2025 if the average share price in the three months ending 9 April 2022 (the "Average Share Price") equals or exceeds 6.00p. At an Average Share Price of 6.00p, 15% of the Options become exercisable, for all of the Options to vest the Average Share Price must equal or exceed 10.00p, and a straight line sliding scale applies to determine the amount vesting if the Average Share Price is between 6.00p and 10.00p. For an £11 million market cap coy current share price 4.5/4.6 I suspect thosse who bought in th elast 4 months would be happy if targets met but long term holders will be disappointed but many who bought 5 years ago may already have sold out.
07/7/2017
18:12
willib2: Doglover2003, Mmmmmm Do you remember making this post. doglover2003 - 02 Aug 2016 - 08:31:29 - 8280 of 8884 When will DEMG overtake LID share price?
23/1/2015
13:33
arf dysg: Well, well, well. A well is a deep hole, into which the LID share price has dropped. Well, well, well, look at that. The LID share price has dropped. It is going down at a rate of knots. One must keep an open mind about future trends in the Lid to Deltex price ratio.
Lidco share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
LID
Lidco
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200604 18:13:06